Loading…
Lobbying Spend
—
Filings
9
Firms Hired
1
Active Period
2020–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Restoring the America Invents Act
2021 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Patent thickets and patent reform, Restoring the America Invents Act (S. 2891).
Client expense: — · Firm income: $60,000
Matched citations: S. 2891
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4455
Increasing Access to Biosimilars Act of 2020
2020 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6179
Increasing Access to Biosimilars Act of 2020
2020 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: S. 4134
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4455
Increasing Access to Biosimilars Act of 2020
2020 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6179
Bring Entrepreneurial Advancements To Consumers Here In North America Act
2020 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BEAT China Act (H.R. 6690).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6690
Increasing Access to Biosimilars Act of 2020
2020 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: S. 4134
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4455
Increasing Access to Biosimilars Act of 2020
2020 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6179
Bring Entrepreneurial Advancements To Consumers Here In North America Act
2020 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BEAT China Act (H.R. 6690).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6690
Increasing Access to Biosimilars Act of 2020
2020 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
The BIOSIM Act (H.R. 4455); The Increasing Access to Biosimilars Act (H.R. 6179/S. 4134); Medicaids Consumer Price Index (CPI) penalty for generics; and Policies to incentivize biosimilars.
Client expense: — · Firm income: $60,000
Matched citations: S. 4134
Source: Senate LDA